Cargando…
Risk of cardiac‐related mortality in stage IIIA‐N2 non‐small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database
BACKGROUND: In this study, we aimed to investigate the association between postoperative radiotherapy (PORT) and cardiac‐related mortality in patients with stage IIIA‐N2 non‐small cell lung cancer (NSCLC) using the Surveillance, Epidemiology, and End Results (SEER) database. METHODS: The United Stat...
Autores principales: | Sun, Xin, Men, Yu, Wang, Jianyang, Bao, Yongxing, Yang, Xu, Zhao, Maoyuan, Sun, Shuang, Yuan, Meng, Ma, Zeliang, Hui, Zhouguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088942/ https://www.ncbi.nlm.nih.gov/pubmed/33728811 http://dx.doi.org/10.1111/1759-7714.13908 |
Ejemplares similares
-
Postoperative radiotherapy improves survival of patients with ypN2 non‐small cell lung cancer after neoadjuvant chemotherapy followed by surgery – A propensity score matching study of the Surveillance, Epidemiology, and End Results database
por: Bao, Yongxing, et al.
Publicado: (2021) -
Additional Radiotherapy With or Without Chemotherapy Following
Endoscopic Resection for Stage I Esophageal Carcinoma: A Pilot
Study
por: Yang, Xu, et al.
Publicado: (2021) -
Postoperative radiotherapy for pathological stage IIIA‐N2 non‐small cell lung cancer with positive surgical margins
por: Yuan, Meng, et al.
Publicado: (2020) -
Famitinib enhances the antitumor effect of radioimmunotherapy in murine lung cancer
por: Yuan, Meng, et al.
Publicado: (2022) -
Anlotinib Enhances the Antitumor Activity of High-Dose Irradiation Combined with Anti-PD-L1 by Potentiating the Tumor Immune Microenvironment in Murine Lung Cancer
por: Yuan, Meng, et al.
Publicado: (2022)